Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | HMGCR | P04035 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 4/20 | 0.38 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.38 |
| ▸ | CPT2 | P23786 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL735448 | 0.97 | ALDH1A1 (0.79) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL3942871 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL1932644 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL10561739 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL25332361 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL25331832 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL6657507 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL8647305 | 0.95 | ALDH1A1 (0.75) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL8032258 | 0.93 | ALDH1A1 (0.71) | ALDH1A1CA4HMGCRCHRM1TBXA2R | |
| Citric Acid SCHEMBL5030701 | 0.92 | ALDH1A1 (0.79) | ALDH1A1CA4HMGCRCHRM1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106420886-A | Composition with physical fatigue alleviating and immunity enhancing functions, and preparation method thereof | 珠海宝德润生健康科技有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106177746-A | A kind of to chemical liver injury compositions with auxiliary protection function and preparation method thereof | 北京宝德润生医药科技发展有限公司 | 2016-12-07 | — | — | CN | disclosed |
| CN-106177166-A | A kind of compositions with function of physical fatigue alleviation and preparation method thereof | 北京宝德润生医药科技发展有限公司 | 2016-12-07 | — | — | CN | disclosed |
| CN-105770715-A | Composition with blood sugar lowering function, and preparation method thereof | 北京宝德润生医药科技发展有限公司 | 2016-07-20 | — | — | CN | disclosed |
| CN-105767718-A | Composition with function of dispelling chloasma and preparation method of composition | 北京宝德润生医药科技发展有限公司 | 2016-07-20 | — | — | CN | disclosed |
| CN-101214257-A | Medicinal composition for treating diabetes chronic complication and preparation method thereof | BEIJING RUNDEKANG MEDICAL TECH (CN) | 2008-07-09 | — | — | CN | disclosed |
| CN-101199519-A | Combination containing clacillin or derivative and preparing method thereof | BEIJING RUNDEKANG MEDICAL TECH (CN) | 2008-06-18 | — | — | CN | disclosed |
| CN-101185655-A | Medicinal composition for treating diabetes chronic complication and preparation method thereof | BEIJING RUNDEKANG MEDICAL TECH (CN) | 2008-05-28 | — | — | CN | disclosed |
| EP-0549663-A4 | — | — | 1994-02-16 | — | — | EP | disclosed |
| EP-0549663-A1 | COLOR CHANGE MOUTHRINSE. | BEECHAM INC (US) | 1993-07-07 | — | — | EP | disclosed |